Condition 1: Stroke. Condition 2: Dysphagia. Fulfills criteria for stroke in that acute symptoms of focal brain injury that have lasted 24 hours or more (or led to death before 24 hours), but subtype of stroke (ischemic or haemorrhagic) has not been determined by neuroimaging or other techniques. Difficulty in swallowing which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the phar
Conditions
Interventions
Intervention 1: Intervention group: This treatment protocol consists of 10 different stimulations in different areas and are performed without the use of medical gloves. These stimulations are priorit
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Patients were included in the sample if they were in the acute phase of the stroke (the first 30 days after the stroke) Patients were over 18 years of age and younger than 90 years Patients suffered from stroke-related dysphagia (in the oral and pharyngeal phases) Patients had to have a normal level of consciousness
Exclusion criteria
Exclusion criteria: The patients were unwilling to participate in this study (non-cooperation or non-attendance) The patients could not collaborate in the swallowing examination because of low consciousness and low comprehension The recurrence of stroke Incidence of other neurological disorders that affect dysphagia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Swallowing Disorder. Timepoint: Swallowing disorder is measured by Mann assessment swallowing ability (MASA) test at the beginning of the study (before the start of the study) and 7, 14, 21, 28 and 35 days after the intervention. Method of measurement: Mann assessment swallowing ability (MASA) test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Oral Movements. Timepoint: Oral movements are measured by the Motility function test at the beginning of the study (before the start of the study) and 7, 14, 21, 28 and 35 days after the intervention. Method of measurement: Motility function test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtefe Hoseinzade
Shiraz University of Medical Sciences
Outcome results
None listed